2025 annual financial data
Immunome 2025 Operating margin
Immunome 2025 operating margin with verified reported values.
Direct answer
Operating margin was -3,084.76%.
Operating income was -214,113,000 USD and net income was -212,394,000 USD.
Operating cash flow was -190,919,000 USD.
Get free Immunome email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,941,000 USD
- Operating income
- -214,113,000 USD
- Net income
- -212,394,000 USD
- Operating cash flow
- -190,919,000 USD